- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about DNLI
Recent news which mentions DNLI
Biogen and Denali Realign Parkinson's Disease Research Priorities Amidst R&D Restructure
June 05, 2023
From Benzinga
Denali Therapeutics Reveals New Interim Data From Early-Stage Hunter Syndrome Study
February 23, 2023
Tickers
DNLI
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023
January 30, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022
December 05, 2022
From Benzinga
Why Denali Therapeutics' Stock Rose 6.6% on Wednesday
November 02, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
November 02, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 18, 2022
From Benzinga
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
September 29, 2022
From Benzinga
Netflix, Biogen And Other Big Gainers From Wednesday
September 29, 2022
From Benzinga
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
September 28, 2022
From Benzinga
From Motley Fool
From Benzinga
These stocks soared during the pandemic, and then crashed. Ten are now expected to double in price.
May 02, 2022
From MarketWatch
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
From Benzinga
4 Undervalued Biotech Stocks to Add to Your Buy List
April 20, 2022
From InvestorPlace
7 F-Rated Stocks to Avoid During the Downturn
March 23, 2022
From InvestorPlace
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
From Benzinga
12 biotech stocks to consider buying now as prospects for the sector brighten this year
February 06, 2022
From MarketWatch
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
From Benzinga
48 Biggest Movers From Yesterday
January 14, 2022
From Benzinga
Why Denali Therapeutics Stock Is Sinking This Week
January 13, 2022
From Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
January 13, 2022
From Benzinga
Mid-Afternoon Market Update: Nasdaq Dips 250 Points; Taiwan Semiconductor Shares Gain
January 13, 2022
From Benzinga
26 Stocks Moving In Thursday's Mid-Day Session
January 13, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.